文献速递生殖医学

山奈酚改善小鼠排卵后卵母细胞老化:体外与体内研究

Kaempferol ameliorates in-vitro and in-vivo postovulatory oocyte ageing in mice.
PubMed 文献 · Reprod Biomed Online · 2022-07-19

该研究通过体外和体内实验探讨山奈酚对小鼠排卵后卵母细胞老化的缓解作用。体外将成熟卵母细胞在含山奈酚培养液中培养12小时,体内小鼠灌胃给药21天。结果显示山奈酚部分改善老化卵母细胞的受精能力(原核率69.08±2.37% vs 老化组38.95±3.58%)和早期胚胎发育(囊胚率50.02±3.34% vs 30.83±5.46%),并改善不良妊娠结局,作者认为其可能是有潜力的天然抗氧化剂,需进一步临床试验。

要点

  • 山奈酚可部分改善老化卵母细胞的受精能力,原核率69.08±2.37% vs 老化组38.95±3.58%。
  • 山奈酚可部分改善老化卵母细胞的早期胚胎发育,囊胚率50.02±3.34% vs 老化组30.83±5.46%。
  • 作者认为山奈酚可能是有潜力的天然抗氧化剂,需进一步临床试验。

核心结论

  • 山奈酚可能是有潜力的天然抗氧化剂,对畜牧业有意义,并可能有助于提高IVF和ICSI的成功率,需进一步临床试验。

研究设计与样本

  • 体外实验:成熟卵母细胞在含山奈酚的培养液中培养12小时。
  • 体内实验:小鼠灌胃给予适量山奈酚21天。
  • 采用免疫荧光评估纺锤体形态和染色体排列、氧化应激水平及间隙连接。
  • 采用IVF检测各卵母细胞组的受精能力和早期胚胎发育能力。
  • 采用RNA测序和定量聚合酶链反应鉴定山奈酚缓解体内排卵后卵母细胞老化的细胞通路。

主要发现

  • 山奈酚改变了老化卵母细胞中的多种过程,包括氧化应激、过氧化物酶体、TNF信号、cAMP信号和间隙连接通路。
  • Sirt1、Mapk1、Ampk和Foxo3等重要基因的表达受到调控。
  • 山奈酚改善了受精老化卵母细胞的不良妊娠结局。
  • IVF结果显示山奈酚可部分抵消卵母细胞老化对受精能力的影响:原核率山奈酚组69.08±2.37% vs 老化组38.95±3.58%。
  • IVF结果显示山奈酚可部分抵消卵母细胞老化对早期胚胎发育的影响:囊胚率山奈酚组50.02±3.34% vs 老化组30.83±5.46%。

关键数值与推荐

  • 山奈酚组原核率69.08±2.37% vs 老化组38.95±3.58%。
  • 山奈酚组囊胚率50.02±3.34% vs 老化组30.83±5.46%。

临床怎么用

  • 作者认为山奈酚可能是有潜力的天然抗氧化剂,对畜牧业有意义,并可能有助于提高IVF和ICSI的成功率。
  • 作者指出需进一步临床试验。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does kaempferol alleviate postovulatory oocyte ageing, thereby maintaining their early embryonic development capacity? DESIGN: The effects of kaempferol on postovulatory ageing were investigated in vitro and in vivo by short-term kaempferol administration (mature oocytes were cultured in a kaempferol-containing medium for 12 h; mice were intragastrically administered with the appropriate amount of kaempferol for 21 days). Spindle morphology and chromosome alignment, levels of oxidative stress and the gap junction were assessed by immunofluorescence. Fertilization ability and early embryonic development ability of each oocyte group was detected by IVF. Fertilization of the ageing oocyte model was used to explore whether kaempferol could improve adverse pregnancy outcome. RNA-sequencing and quantitative polymerase chain reaction were used to identify the cellular pathways through which kaempferol relieves postovulatory oocyte ageing in vivo. RESULTS: Kaempferol administration altered various processes in the ageing oocytes, including oxidative stress, the peroxisome, TNF signalling, cAMP signalling and the gap junction pathway. Expression of several important genes, such as Sirt1, Mapk1, Ampk and Foxo3, was regulated. Moreover, kaempferol ameliorated adverse pregnancy outcomes of fertilized ageing oocytes. IVF results indicate that kaempferol could partially counteract the effects of oocyte ageing on fertilization capacity (pronucleus: kaempferol, 69.08 ± 2.37% versus aged, 38.95 ± 3.58%) and early embryonic development (blastocyst: kaempferol, 50.02 ± 3.34% versus aged, 30.83 ± 5.46%). CONCLUSIONS: Our results indicate that kaempferol may be a potent natural antioxidant, have implications for animal husbandry and may help improve the success rate of IVF and ICSI. Further clinical trials are needed.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Zeng ZC, Jiang J, Wang XJ, et al. Kaempferol ameliorates in-vitro and in-vivo postovulatory oocyte ageing in mice. Reprod Biomed Online. 2022. PMID: 36280424. doi:10.1016/j.rbmo.2022.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。